The Role of Neoadjuvant Therapy in Sphincter-Saving Surgery for Mid and Distal Rectal Cancer
Authors:
- José G. GuillemJGJosé G. Guillem
- 26 October 2009
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 28 (3) , 259-267
Abstract
Current treatment of mid and lower rectal cancer includes neoadjuvant therapy, such as radiotherapy or radiochemotherapy. Randomized trials have demonstrated that neoadjuvant therapy improves local control. However, with the exception of one study, it does not improve overall and cancer-specific survival. In addition, the role of neoadjuvant therapy in enhancing the surgeon's ability to perform sphincter-saving surgery is still controversial. We provide an overview of reported randomized trials using neoadjuvant therapy in patients with rectal cancer. We have examined the most significant factors influencing sphincter preservation and the manner in which these factors are affected by neoadjuvant treatment.Keywords
This publication has 66 references indexed in Scilit:
- A Prospective Pathologic Analysis Using Whole-Mount Sections of Rectal Cancer Following Preoperative Combined Modality TherapyAnnals of Surgery, 2007
- A Pathologic Complete Response of Rectal Cancer to Preoperative Combined-Modality Therapy Results in Improved Oncological Outcome Compared With Those Who Achieve No Downstaging on the Basis of Preoperative Endorectal UltrasonographyAnnals of Surgical Oncology, 2006
- Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3cm of the anal vergeEuropean Journal of Surgical Oncology, 2006
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyRadiotherapy and Oncology, 2004
- Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapyCancer, 2002
- Complete Response to Neoadjuvant Chemoradiation for Rectal Cancer Does Not Influence SurvivalAnnals of Surgical Oncology, 2001
- Adenocarcinoma of the Lower Third of the Rectum Surgically Treated With a <10-MM Distal Clearance: Preliminary Results in 35 N0 PatientsAnnals of Surgical Oncology, 2001
- Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failureEuropean Journal of Cancer, 1994
- Distal intramural spread of rectal carcinomasDiseases of the Colon & Rectum, 1986